
Indian inflation is back in focus as higher food and oil costs pressure household budgets and raise questions about interest rates. That kind of backdrop often rewards businesses that can still grow earnings and keep their finances in reasonable shape. This article looks at three stocks picked from a screen of Indian companies where analysts see strong profit growth potential over the next three years, and breaks down why each might deserve a closer look.
The three stocks highlighted below are just a starting sample, since the full screen surfaced 139 more Indian companies with similar earnings growth expectations and financial profiles that this article does not cover.
To identify and analyze the highest conviction ideas for your watchlist, head straight to the Healthy high growth potential screener
Shaily Engineering Plastics plugs directly into the Healthy high growth potential theme through its precision drug delivery devices and pharma CDMO work, giving you exposure to growing healthcare demand while still being backed by a broader engineered plastics business.
Shaily Engineering Plastics manufactures precision injection moulded components, including inhalers, injector pens, auto injectors and pharma packaging that tie it closely to higher growth healthcare markets, alongside consumer, industrial and furniture products. It generated ₹10,246 million from customised plastic and other materials and has a market cap of about ₹140.3b.
"Although the GLP-1 opportunity is expanding rapidly worldwide and Shaily has onboarded a large roster of generic players across multiple countries, delays in regulatory approvals or slower than expected generic capture from innovators could cap utilization of its expanded pen capacity and temper healthcare revenue growth."
What happens to margins and growth expectations if a single key assumption about future device demand and pricing starts to slip?
If that single pressure point matters to your thesis, read the full narrative for Shaily Engineering Plastics to see how Shaily Engineering Plastics could still accelerate or stall from here.
Sky Gold and Diamonds leans into the Healthy high growth potential theme through its focus on branded and lab-grown jewellery, channelling rising organised retail demand into a tightly run manufacturing and distribution engine.
"Accelerating shift from unorganised to organised jewellery retail, supported by lightweight machine made designs and wider national distribution, is deepening wallet share with large chains and is expected to sustain high volume growth."
What that means for future margins and earnings depends on how one ambitious expansion plan copes with a single pressure point in its funding mix.
That funding mix question is exactly where the story gets interesting, so read the full narrative for Sky Gold and Diamonds to see how Sky Gold and Diamonds could convert that risk into accelerating scale.
Timex Group India is a branded watch manufacturer and retailer anchored in the Timex and licensed labels, which ties it closely to the Healthy high growth potential theme. It generated about ₹8,486 million from watches and after sales services and has a market cap near ₹71.7b.
Timex Group India has earnings forecast to grow about 31.8% a year over the next 3 years and recently reported Q1 FY2026-27 revenue of ₹2,194.5 million with net income of ₹250.2 million, supported by an acceptable financial position. Future returns from that watch led growth path depend on how one unseen pressure shapes buyer demand and pricing power.
That unseen pressure on pricing and demand is exactly what shows up in the 2 key rewards and 1 important warning sign, so you can see where Timex Group India could really accelerate.
Fresh ideas move first. Breakout stories can gain momentum while prices are still under the radar for now. Consider taking action before conditions change.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com